U.S. Candida auris cases near 700

The case count jumped by 71 in the span of one month


The Centers for Disease Control and Prevention (CDC) recently reported that as of April 30, there were 684 cases of Candida auris in the U.S., according to an article on the Becker's Clinical Leadership and Infection Control website.

The case count jumped by 71 in the span of one month from March 31.

Illinois, New Jersey and New York are still reporting the highest number of cases. New York has the most with 334 confirmed and four probable cases.

C. auris cases also have been reported in Australia, Canada, China, Colombia, France, Germany and India.

Read the article.



June 26, 2019


Topic Area: Infection Control


Recent Posts

Reframing the Construction Manager as a Community Manager

Managers must work with patients, community residents and other interested parties to ensure a smooth, successful construction projects


Health First Celebrates 'Topping Off' Ceremony for New Cape Canaveral Hospital Campus

Construction is slated to finish by the end of 2026 or early 2027.


The University of Hawai'i Cancer Center Caught Up in Cyberattack

Investigations are still ongoing to assess other sensitive information that may have been impacted.


Mature Dry Surface Biofilm Presents a Problem for Candida Auris

Multiple methods are described in the literature, but no consensus has been reached for disinfection efficacy tests against biofilms.


Sutter Health's Arden Care Center Officially Opens

With an adaptive reuse of an underutilized office building, the 70,000 square-foot facility was renovated to meet current healthcare standards.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.